SOCS3 expression correlates with severity of inflammation in mouse hepatitis virus strain 3-induced acute liver failure and HBV-ACLF

Abstract

Recently, suppressor of cytokine signaling-3 (SOCS3) has been shown to be an inducible endogenous negative regulator of Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway which is relevant in inflammatory response, while its functions in acute liver failure and HBV-induced acute-on-chronic liver failure (HBV-ACLF) have not been fully elucidated. In this study, we explored the role of SOCS3 in the development of mouse hepatitis virus strain 3 (MHV-3)-induced acute liver failure and its expression in liver and peripheral blood mononuclear cells (PBMCs) of patients with HBV-ACLF. Inflammation-related gene expression was detected by real-time PCR, immunohistochemistry and Western blotting. The correlation between SOCS3 level and liver injury was studied. Our results showed that the SOCS3 expression was significantly elevated in both the liver tissue and PBMCs from patients with HBV-ACLF compared to mild chronic hepatitis B (CHB). Moreover, a time course study showed that SOCS3 level was increased remarkably in the liver of BALB/cJ mice at 72 h post-infection. Pro-inflammatory cytokines, interleukin (IL)-1β, IL-6, and tumor necrosis factor (TNF)-α, were also increased significantly at 72 h post-infection. There was a close correlation between hepatic SOCS3 level and IL-6, and the severity of liver injury defined by alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels, respectively. These data suggested that SOCS3 may play a pivotal role in the pathogenesis of MHV-3-induced acute liver failure and HBV-ACLF.

Keywords

suppressors of cytokine signaling-3; HBV-induced acute-on-chronic liver failure; mouse hepatitis virus strain 3; fulminant liver failure; BALB/cJ mice

References

[1] KwonH, LokAS. Hepatitis B therapy. Nat Rev Gastroenterol Hepatol, 2011, 8(5): 275-284

[2] EngelmannC, BergT. Acute and acute-on chronic-liver failure. Dtsch Med Wochenschr, 2013, 138(31–32): 1574-1577

[3] LeeWM. Acute liver failure in the United States. Semin Liver Dis, 2003, 23(3): 217-226

[4] VaqueroJ, BleiAT. Etiology and management of fulminant hepatic failure. Curr Gastroenterol Rep, 2003, 5(1): 39-47

[5] MurrayPJ. The JAK-STAT signaling pathway: input and output integration. J Immunol, 2007, 178(5): 2623-2629

[6] StarrR, HiltonDJ. Negative regulation of the JAK/STAT pathway. Bioessays, 1999, 21(1): 47-52

[7] RakeshK, AgrawalDK. Controlling cytokine signaling by constitutive inhibitors. Biochem Pharmacol, 2005, 70(5): 649-657

[8] TamiyaT, KashiwagiI, TakahashiR, et al.. Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol, 2011, 31(5): 980-985

[9] AlexanderWS, HiltonDJ. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu Rev Immunol, 2004, 22: 503-529

[10] ChenYH, HsiehSC, ChenWY, et al.. Spontaneous resolution of acute gouty arthritis is associated with rapid induction of the anti-inflammatory factors TGFbeta1, IL-10 and soluble TNF receptors and the intracellular cytokine negative regulators CIS and SOCS3. Ann Rheum Dis, 2011, 70(9): 1655-1663

[11] AntônioJ, SouzaCD, VilasA, et al.. SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo. Mediat Inflamm, 2013, 35(2): 52-63

[12] BoyleK, ZhangJG, NicholsonSE, et al.. Deletion of the SOCS box of suppressor of cytokine signaling 3 (SOCS3) in embryonic stem cells reveals SOCS box-dependent regulation of JAK but not STAT phosphorylation. Cell Signal, 2009, 21(3): 394-404

[13] KimuraA, KinjyoI, MatsumuraY, et al.. SOCS3 is a physiological negative regulator for granulopoiesis and granulocyte colony-stimulating factor receptor signaling. J Biol Chem, 2004, 279(8): 6905-6910

[14] OgataH, KobayashiT, ChinenT, et al.. Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis. Gastroenterology, 2006, 131(1): 179-193

[15] QinH, HoldbrooksAT, LiuY, et al.. SOCS3 deficiency promotes M1 macrophage polarization and inflammation. J Immunol, 2012, 189(7): 3439-3448

[16] KoeberleinB, zur HausenA, BektasN, et al.. Hepatitis B virus overexpresses suppressor of cytokine signaling-3 (SOCS3) thereby contributing to severity of inflammation in the liver. Virus Res, 2010, 148(1–2): 51-59

[17] ZhuC, SunY, LuoX, et al.. Novel mfgl2 antisense plasmid inhibits murine fgl2 expression and ameliorates murine hepatitis virus type 3-induced fulminant hepatitis in BALB/cJ mice. Hum Gene Ther, 2006, 17(6): 589-600

[18] SchindlerC, LevyDE, DeckerT. JAK-STAT signaling: from interferons to cytokines. J Biol Chem, 2007, 282(28): 20 059-20 063

[19] OkadaS, NakamuraM, KatohH, et al.. Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med, 2006, 12(7): 829-834

[20] YoshimuraA, OhishiHMM, AkiD, et al.. Regulation of TLR signaling and inflammation by SOCS family proteins. J Leukoc Biol, 2004, 75(3): 422-427

[21] de SouzaJA, NogueiraAV, de SouzaPP, et al.. Expression of suppressor of cytokine signaling 1 and 3 in ligature-induced periodontitis in rats. Arch Oral Biol, 2011, 56(10): 1120-1128

[22] WhiteGE, CotterillA, AddleyMR, et al.. Suppressor of cytokine signalling protein SOCS3 expression is increased at sites of acute and chronic inflammation. J Mol Histol, 2011, 42(2): 137-151

[23] ChenT, ZhuL, ZhouY, et al.. KCTD9 contributes to liver injury through NK cell activation during hepatitis B virus-induced acute-on-chronic liver failure. Clin Immunol, 2013, 146(3): 207-216

[24] ZouY, ChenT, HanM, et al.. Increased killing of liver NK cells by Fas/Fas ligand and NKG2D/NKG2D ligand contributes to hepatocyte necrosis in virus-induced liver failure. J Immunol, 2010, 184(1): 466-475

[25] KimK, KimKH, CheongJ. Hepatitis B virus X protein impairs hepatic insulin signaling through degradation of IRS1 and induction of SOCS3. PLoS One, 2010, 5(3): e8649-e8649

[26] CrokerBA, KrebsDL, ZhangJG, et al.. SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol, 2003, 4(6): 540-545

[27] FischerP, LehmannU, SobotaRM, et al.. The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling. Biochem J, 2004, 378(Pt2): 449-460

[28] JoD, LiuD, YaoS, et al.. Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis. Nat Med, 2005, 11(8): 892-898

[29] GalunE, AxelrodJH. The role of cytokines in liver failure and regeneration: potential new molecular therapies. Biochim Biophys Acta, 2002, 1592(3): 345-358

[30] YangXP, SchaperF, TeubnerA, et al.. Interleukin-6 plays a crucial role in the hepatic expression of SOCS3 during acute inflammatory processes in vivo. J Hepatol, 2005, 43(4): 704-710